Comparison of the Effectiveness and Hypocalcemia Risk of Antiresorptive Agents in Patients with Hypercalcemia of Malignancy
Denosumab and IV BP were similarly effective in reducing calcium levels. However, IV BP combined with calcitonin yielded a more rapid and pronounced decrease.
Authors
- Seung Shin Park (ORCID: https://orcid.org/0000-0001-5719-1539)
- Sung Hye Kong (ORCID: https://orcid.org/0000-0002-8791-0909)
- Sang Wan Kim (ORCID: https://orcid.org/0000-0001-9561-9110)
- Chan Soo Shin (ORCID: https://orcid.org/0000-0002-5829-4465)
- Se Hyun Kim (ORCID: https://orcid.org/0000-0002-2292-906X)
- Jung Hee Kim (ORCID: https://orcid.org/0000-0001-5435-6166)
- Jee Hyun Kim (ORCID: https://orcid.org/0000-0002-2584-108X)
Institutions
- Seoul National University (KR)
- Seoul Metropolitan Government (KR)
- Seoul National University Hospital (KR)
- Seoul National University Bundang Hospital (KR)
- SNUH SMG-SNU Boramae Medical Center (KR)
Publication Details
- Journal
- Endocrinology and Metabolism
- Published
- 2025-02-04
- DOI
- https://doi.org/10.3803/enm.2024.2132
- Citations
- 1
- Primary Topic
- Bone health and treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.05